| Formulation of new biologics to be used as subcutaneous (SC) injections is a developmental strategy aimed at improving patient comfort and/or reducing costs. |
| SC trastuzumab is a therapeutic option approved to treat HER2-positive (HER2+) breast cancer in Brazil and Europe. |
| To date, there are no safety or efficacy data on SC trastuzumab and intravenous pertuzumab combination therapy. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.